haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Victoria/4897/2022 (H1N1)-pdm09: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Thailand/8/2022 (H3N2)-like: reassortant virus derived from A/California/122/2022, SAN-022) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Austria/1359417/2021 -like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.01 mg, kalium 0.08 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum.
Packungsbestandteile
Source
Data was imported : 05.09.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
